{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:16:32Z","timestamp":1775852192959,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013287","name":"Hercule Programmes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G013118N"],"award-info":[{"award-number":["G013118N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201708440366"],"award-info":[{"award-number":["201708440366"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012541","name":"Herculesstichting","doi-asserted-by":"publisher","award":["AUGE\/17\/22"],"award-info":[{"award-number":["AUGE\/17\/22"]}],"id":[{"id":"10.13039\/501100012541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijpddr.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T05:11:50Z","timestamp":1628226710000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents"],"prefix":"10.1016","volume":"17","author":[{"given":"Cai","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Hulpia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izet","family":"Karalic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurens","family":"De Schepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-1264","authenticated-orcid":false,"given":"Serge","family":"Van Calenbergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2021.08.001_bib1","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.2174\/092986710791556023","article-title":"Inhibitors of the purine salvage pathway: a valuable approach for antiprotozoal chemotherapy?","volume":"17","author":"Berg","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2015.12.017","article-title":"Current drug therapy and pharmaceutical challenges for Chagas disease","volume":"156","author":"Bermudez","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.aaa3683","article-title":"Infectious diseases. Overcoming neglect of kinetoplastid diseases","volume":"348","author":"Bilbe","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib4","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1021\/jm2005173","article-title":"Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines","volume":"54","author":"Bourderioux","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib5","doi-asserted-by":"crossref","first-page":"113290","DOI":"10.1016\/j.ejmech.2021.113290","article-title":"Synthesis and evaluation of 3'-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents","volume":"216","author":"Bouton","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib7","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human african trypanosomiasis","volume":"390","author":"Buscher","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0024-3205(81)90062-X","article-title":"Selective killing of Leishmania infected mouse macrophages by 6-methylpurine 2'-deoxyriboside","volume":"29","author":"Carson","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/ETLS20170103","article-title":"Antileishmanial and antitrypanosomal drug identification","volume":"1","author":"Croft","year":"2017","journal-title":"Emerg Top Life Sci"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1112181","article-title":"Comparative genomics of trypanosomatid parasitic protozoa","volume":"309","author":"El-Sayed","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3389\/fimmu.2018.01493","article-title":"Human kinetoplastid Protozoan infections: where are we going next?","volume":"9","author":"Filardy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib14","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1021\/jo034351i","article-title":"An efficient synthesis of 2-substituted 6-methylpurine bases and nucleosides by Fe- or Pd-catalyzed cross-coupling reactions of 2,6-dichloropurines","volume":"68","author":"Hocek","year":"2003","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib15","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1016\/j.bmcl.2010.10.076","article-title":"Synthesis and anti-HCV activity of a new 2'-deoxy-2'-fluoro-2'-C-methyl nucleoside analogue","volume":"20","author":"Hu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib16","doi-asserted-by":"crossref","first-page":"112018","DOI":"10.1016\/j.ejmech.2019.112018","article-title":"C6-O-alkylated 7-deazainosine nucleoside analogues: discovery of potent and selective anti-sleeping sickness agents","volume":"188","author":"Hulpia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/acsinfecdis.0c00105","article-title":"Structure-activity relationship exploration of 3'-Deoxy-7-deazapurine nucleoside analogues as anti-trypanosoma brucei agents","volume":"6","author":"Hulpia","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejmech.2018.12.050","article-title":"Revisiting tubercidin against kinetoplastid parasites: aromatic substitutions at position 7 improve activity and reduce toxicity","volume":"164","author":"Hulpia","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib19","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1038\/s41467-019-13522-6","article-title":"Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness","volume":"10","author":"Hulpia","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib20","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1021\/acs.jmedchem.8b00999","article-title":"Discovery of novel 7-aryl 7-deazapurine 3'-Deoxy-ribofuranosyl nucleosides with potent activity against trypanosoma cruzi","volume":"61","author":"Hulpia","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib22","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1016\/S0021-9258(19)86874-6","article-title":"Nucleosidases from Leishmania donovani. Pyrimidine ribonucleosidase, purine ribonucleosidase, and a novel purine 2'-deoxyribonucleosidase","volume":"254","author":"Koszalka","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008028","article-title":"Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo","volume":"14","author":"Kuemmerle","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib24","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/cmdc.202100144","article-title":"6-Methyl-7-Aryl-7-Deazapurine nucleosides as anti-trypanosoma cruzi agents: structure-activity relationship and in vivo efficacy","volume":"16","author":"Lin","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib25","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1021\/acs.jmedchem.9b01275","article-title":"Discovery of pyrrolo[2,3-b]pyridine (1,7-dideazapurine) nucleoside analogues as anti-trypanosoma cruzi agents","volume":"62","author":"Lin","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2016.01.005","article-title":"Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents","volume":"129","author":"Lin","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2017.11.005","article-title":"Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents","volume":"149","author":"Lin","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pt.2016.03.005","article-title":"Illuminating parasite protein production by ribosome profiling","volume":"32","author":"Marilyn Parsons","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","article-title":"Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial","volume":"391","author":"Mesu","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbapap.2005.08.018","article-title":"Protein kinases as drug targets in trypanosomes and Leishmania","volume":"1754","author":"Naula","year":"2005","journal-title":"Bba-Proteins Proteom"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/jm4018948","article-title":"Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides","volume":"57","author":"Naus","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/jm901428k","article-title":"6-(Het)aryl-7-Deazapurine ribonucleosides as novel potent cytostatic agents","volume":"53","author":"Naus","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"Perez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1039\/c3md00232b","article-title":"6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents","volume":"4","author":"Perlikova","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1021\/acsinfecdis.8b00298","article-title":"Drug discovery for kinetoplastid diseases: future directions","volume":"5","author":"Rao","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib37","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1021\/jm500497v","article-title":"Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides","volume":"57","author":"Snasel","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.08.001_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0031182016002523","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"145","author":"Uliana","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib39","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.ijpddr.2021.08.001_bib40","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm100593s","article-title":"Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses","volume":"53","author":"Wu","year":"2010","journal-title":"J. Med. Chem."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:52:36Z","timestamp":1761922356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320721000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"alternative-id":["S2211320721000373"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.08.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}